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I N T R O D U C T I O N
The CFTR is the major Cl channel found in the apical 
membrane of intestinal and airway epithelial cells. PKA 
phosphorylates and opens CFTR (Barrett, 2000; Barrett 
and Keely, 2000; Huang et al., 2000). Therefore, most 
studies on intestinal and airway Cl secretion have fo-
cused on PKA as the downstream target of cAMP. Two 
major intracellular cAMP receptors are now known to me-
diate cAMP effects in vivo: the classical cAMP-dependent 
PKA pathway and the recently discovered exchange 
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protein directly activated by cAMP (Epac). Epac, upon 
binding of cAMP, activates PKA-independent signaling 
cascades via small G proteins (de Rooij et al., 1998; 
Kawasaki et al., 1998). Many cAMP-mediated physiological 
processes that were previously thought to be solely me-
diated by PKA have now been shown to be mediated in 
parallel by Epac (Bos, 2006). For instance, glucagon-
like peptide 1 is a cAMP-elevating agent. It stimulates 
insulin secretion in pancreatic  cells via both PKA- and 
Epac-dependent pathways, and the latter involves Ca2+-
dependent exocytosis of insulin granules and inhibition 
of ATP-sensitive K+ channels (KATP channels) (Holz, 2004; 
Kang et al., 2008).
Human intestinal T84 cells have been used as a model 
for studying the physiology and regulation of intestinal 
Cl secretion (Dharmsathaphorn and Madara, 1990). The 
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Intestinal Cl secretion is stimulated by cyclic AMP (cAMP) and intracellular calcium ([Ca2+]i). Recent studies 
show that protein kinase A (PKA) and the exchange protein directly activated by cAMP (Epac) are downstream 
targets of cAMP. Therefore, we tested whether both PKA and Epac are involved in forskolin (FSK)/cAMP-stimulated 
Cl secretion. Human intestinal T84 cells and mouse small intestine were used for short circuit current (Isc) mea-
surement in response to agonist-stimulated Cl secretion. FSK-stimulated Cl secretion was completely inhibited 
by the additive effects of the PKA inhibitor, H89 (1 µM), and the [Ca2+]i chelator, 1,2-bis-(o-aminophenoxy)-ethane-
N,N,N’,N’-tetraacetic acid, tetraacetoxymethyl ester (BAPTA-AM; 25 µM). Both FSK and the Epac activator 8-pCPT-
2’-O-Me-cAMP (50 µM) elevated [Ca2+]i, activated Ras-related protein 2, and induced Cl secretion in intact or 
basolateral membrane–permeabilized T84 cells and mouse ileal sheets. The effects of 8-pCPT-2’-O-Me-cAMP were 
completely abolished by BAPTA-AM, but not by H89. In contrast, T84 cells with silenced Epac1 had a reduced Isc 
response to FSK, and this response was completely inhibited by H89, but not by the phospholipase C inhibitor 
U73122 or BAPTA-AM. The stimulatory effect of 8-pCPT-2’-O-Me-cAMP on Cl secretion was not abolished by 
cystic fibrosis transmembrane conductance (CFTR) inhibitor 172 or glibenclamide, suggesting that CFTR chan-
nels are not involved. This was confirmed by lack of effect of 8-pCPT-2’-O-Me-cAMP on whole cell patch clamp 
recordings of CFTR currents in Chinese hamster ovary cells transiently expressing the human CFTR channel. 
Furthermore, biophysical characterization of the Epac1-dependent Cl conductance of T84 cells mounted in 
Ussing chambers suggested that this conductance was hyperpolarization activated, inwardly rectifying, and 
displayed a Cl>Br>I permeability sequence. These results led us to conclude that the Epac-Rap-PLC-[Ca2+]i signal-
ing pathway is involved in cAMP-stimulated Cl secretion, which is carried by a novel, previously undescribed 
Cl channel.
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Institute), U73122 (Enzo Life Sciences, Inc.), Gö6976 and 
CFTRinh-172 (EMD), glibenclamide (Research Biochemicals, Inc.), 
and Epac1 and Epac2 antibodies (sc-28366 and sc-28326, respec-
tively; Santa Cruz Biotechnology, Inc.).
Cell culture and Ussing chamber setup
T84 cells were grown as confluent monolayers in a 1:1 mixture of 
Dulbecco’s modified Eagle’s medium (DMEM) and Ham’s F-12 
medium supplemented with 40 µg/ml penicillin, 90 µg/ml strep-
tomycin, and 10% fetal bovine serum. Only monolayers with resis-
tances in the range of 1,500 to 3,000 Ω·cm2 were used for 
experiments, and these were mounted between two halves of an 
Ussing chamber for short circuit current (Isc) measurement, 
which was done at 37°C with both sides of the monolayer im-
mersed in an oxygenated HCO3-free solution containing (in 
mM) 140 NaCl, 5 KCl, 1 MgCl2, 2 CaCl2, 10 HEPES, and 10 glu-
cose, pH 7.4. 5 ml of fluid in each half of the chamber was con-
nected via KCl agar bridges to voltage and current electrodes and 
clamped at 0 mV using VCC MC6 multi-channel voltage–current 
clamp amplifier (Physiologic Instruments). T84 cells with a stable 
knockdown of Epac1 (T84Epac1KD) were grown on transwell in-
serts in DMEM plus Ham’s F-12 media containing 10 µg/ml puro-
mycin in addition to 40 µg/ml penicillin, 90 µg/ml streptomycin, 
and 10% fetal bovine serum. These cells were also studied using 
the same solution mentioned above for Ussing chambers.
Calcium imaging
T84 cells were grown on glass coverslips. Cells were loaded with 
2 µM Fura 2-AM in HEPES-buffered salt solution (HBSS; in mM: 
135 NaCl, 1.2 MgCl2, 1.2 CaCl2, 10 HEPES, 5 KCl, and 10 glucose, 
pH 7.4) by incubating for 30–45 min in the dark at 37°C, followed 
by a 30-min de-esterification in HBSS containing 5 µM indometh-
acin at room temperature. Fura 2 fluorescence images were moni-
tored at a 510-nm emission with alternating excitation at 340 and 
380 nm as described previously (Merlin et al., 1998). Individual 
Fura-2–loaded T84 cells were selected and [Ca2+]i values were cal-
culated on a pixel-by-pixel basis for data processing using Origin 
software (OriginLab). For calibration of the Ca2+ indicator, a 
Fura-2 Ca2+-imaging calibration kit with 0–10 mM CaEGTA (Invit-
rogen) was used according to the manufacturer’s instructions. All 
measurements shown are representative of a minimum of three 
independent experiments with no fewer than 50 cells calculated 
in each study.
Reverse transcription (RT)-PCR
Total RNA was isolated from T84 cells by TRIZOL reagent (Invit-
rogen). cDNA was synthesized from total RNA using random hex-
amers and superscript II RT. 1 µl of the first-strand cDNA product 
was then used as template for PCR amplification with Taq DNA 
polymerase by 30 thermocycles of 94°C for 1 min, 54°C for 1 min, 
and 72°C for 1 min using oligonucleotides specific for Epac1 
(sense: TTCCTCCAGAAACTCTCAG; antisense: TCAGCTCAT-
GCGCTTCCTG; size of PCR product is 460 bp) and Epac2 (sense: 
CTCATTGAACCTCACGTTCC; antisense: AGTCATCTCCTTC-
ATGCAGG; size of PCR product is 500 bp).
Western blot analysis
Wild-type T84 or Epac-depleted cells (Epac1KDT84) were grown 
to 100% confluency on transwell permeable supports (in 75-mm 
dishes; Corning). Cells were scraped in PBS and then homoge-
nized by sonication in RIPA buffer plus protease inhibitor cocktail 
(1:100; Sigma-Aldrich) to obtain total cell lysates. Total lysates of 
mouse mucosal cells were prepared from scrapings of duodenum, 
jejunum, ileum, or colon as described previously (Hillesheim et al., 
2007). Lysates were analyzed by Western blot using an Epac1 
mouse monoclonal and Epac2 rabbit polyclonal antibody, sec-
ondary polyclonal goat anti–mouse immunoglobulin G conjugated 
current model of Cl secretion involves electroneutral 
Cl entry across the basolateral membrane via the Na+/
K+/2Cl cotransporter, followed by electrogenic Cl exit 
across the apical membrane via Cl channels. Simultane-
ous activation of basolateral K+ channels maintains a fa-
vorable electrical gradient for apical Cl efflux by limiting 
cell depolarization. Because Cl carries a negative charge, 
the positively charged Na+ ion follows the negative charge 
gradient across the epithelial cell layer through cation-
selective tight junctions. Water, which is driven by the 
osmotic gradient, follows the net transepithelial NaCl 
movement (Barrett, 2000; Fuller and Benos, 2000).
Cyclic nucleotides such as cAMP are major regulators 
of Cl secretion in T84 cells. Forskolin (FSK), which 
acts on adenylate cyclase to elevate intracellular cAMP, 
and the cAMP analogue 8-Br-cAMP are commonly used 
to probe the mechanism of PKA-dependent stimulation 
of Cl secretion. However, it appears that PKA may not 
be the only target of cAMP because intracellular cal-
cium ([Ca2+]i) can be elevated in response to FSK and/
or cAMP. For instance, Merlin et al. (1998) previously 
showed that FSK elevates [Ca2+]i by unknown mecha-
nisms in T84 cells. Similarly, FSK/cAMP increases 
[Ca2+]i in chicken enterocytes (Semrad and Chang, 
1987). These observations suggest that FSK elicits Cl 
secretion by activating not only PKA, but also other sig-
naling pathways such as [Ca2+]i. Furthermore, Epac has 
been shown to transduce cAMP into [Ca2+]i signaling 
via PLC, and this effect of Epac is PKA independent 
(Schmidt et al., 2001). Because cAMP and [Ca2+]i are 
major regulators of intestinal Cl secretion, we ask 
whether Epac plays a role in FSK- or cAMP-stimulated 
Cl secretion in intestinal epithelial cells, and whether 
Epac links intracellular cAMP signaling to [Ca2+]i eleva-
tion, thus allowing cAMP to mediate Cl secretion in a 
PKA-dependent and -independent manner. Further-
more, Cl channels are a functionally and structurally 
diverse group, and some are involved in normal fluid 
transport across various epithelia (Kidd and Thorn, 
2000; Hartzell et al., 2005; Verkman and Galietta, 2009). 
The CFTR channel is inhibited by CFTR inhibitor 172 
(CFTRinh-172), and only the CFTR channel has been 
implicated in cAMP-activated Cl secretion in a variety 
of epithelia, including the airway and intestine (Riordan, 
1993). However, the Epac-activated Cl secretion in the 
intestine was resistant to CFTRinh-172, and thus the pres-
ent study also characterizes this new Cl conductance bio-
physically as well as pharmacologically.
M AT E R I A L S  A N D  M E T H O D S
Materials
Cell culture reagents, TRIZOL, Fura2-AM, and BCECF-AM were 
from Invitrogen. All other reagents were obtained from Sigma-
Aldrich, except 8-pCPT-2’-O-Me-cAMP (BioLog Life Science 
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transduced T84 cells were processed and selected with puromy-
cin in a similar manner.
Measurement of Isc in mouse ileal sheets
All of the experimental protocols performed in this study were 
approved by the Institutional Animal Care and Use Committee of 
Johns Hopkins University. Non-fasting male mice (35 g) were 
anesthetized and sacrificed by inhalation of halothane. The distal 
ileum was removed and partially stripped of serosal muscle layers. 
The mucosa was mounted in a tissue slider (2.8 × 11–mm aper-
ture for mouse tissue; area, 0.30 cm2) and bathed at 37°C on both 
sides with an HCO3-free solution, which was continually circulated 
with a gas lift oxygenated with 100% O2. After tissues were mounted, 
the change in Isc was monitored in real time (Hoque et al., 2005).
Measurement of chloride conductance (ICl) in permeabilized 
T84 monolayers
The effects of FSK and 8-pCPT-2’-O-Me-cAMP on apical mem-
brane ICl were assessed after permeabilization of the basolateral 
membrane with 50 µg/ml nystatin and the establishment of a 
basolateral to apical Cl concentration gradient (Lewis et al., 1977; 
Mun et al., 1998). 35 µM ouabain was added to the basolateral 
bath to inhibit the Na+-K+-ATPase (Huflejt et al., 1994). Both api-
cal and basolateral baths were initially filled with a Cl-free/high 
K+ solution containing 10 mM sodium gluconate, 140 mM potassium 
gluconate, 1 mM calcium gluconate, 10 mM glucose, and 10 mM 
HEPES, pH 7.4. After equilibration, the basolateral solution was 
replaced with a high Cl/high K+ solution containing 10 mM 
NaCl, 140 mM KCl, 1 mM MgSO4, 1 mM CaCl2, 10 mM glucose, 
and 10 mM HEPES, pH 7.4. 50 µg/ml nystatin was then added to 
permeabilize the basolateral membrane to potassium and chlo-
ride. Under these conditions, there was an agonist-induced ICl as 
Cl ions from the cell moved down the concentration gradient 
through the Cl channels in the apical membrane. To do a bio-
physical characterization of the Epac-stimulated Cl conductance 
in T84 cells, we measured the I-V relationship. To do this, the volt-
age across the monolayer was sequentially stepped from a holding 
voltage of 0 mV to values between 100 and +100 mV in 20-mV 
increments with a pulse duration of 5 s while the corresponding 
transepithelial currents were recorded. For the graphical repre-
sentation of the I/V relationship, we did not use the customary 
Ussing convention for Iscs, where the voltage is V2-V1, where V1 is 
basolateral and V2 is apical (apical–basolateral). Instead, we used 
the physiological convention of inside–outside, which, when the 
basolateral side has been permeabilized to Cl, can also be 
thought of as basolateral–apical. Using the physiological conven-
tion allows for a comparison of the I/V obtained here to the I/V 
relation of other Cl conductances recorded using patch clamp 
methodology. A 50-s interval between each pulse was sufficient for 
recovery from activation. The protocol was performed as de-
scribed above with basolateral membrane-permeabilized T84 cells 
and after sustained stimulation with FSK or 8-pCPT-2’-O-Me-
cAMP. Finally, we investigated the selectivity of the FSK-activated, 
CFTR-inhibited Epac-mediated Cl currents by substituting high 
concentrations of either I (150 mM) or Br (150 mM) on the 
basolateral side to measure the resulting Isc in permeabilized 
membranes. The nystatin permeability of Cl, Br, and I is based 
on their hydrated radius (Cass et al., 1970), which is nearly identi-
cal (3.32, 3.30, and 3.31 Å) (Conway, 1981). Therefore, we have 
assumed an equal nystatin permeability for our selectivity experi-
ments. The relative permeability of Cl, Br, and I was calcu-
lated from the Goldman-Hodgkin-Katz equation. Various blockers 
of epithelial chloride channels such as Zn, Cd, 4,4’-diisothiocya-
natostilbene-2,2’-disulphonic acid (DIDS), 5-nitro-2-(3-phenyl-
propylamino)-benzoate (NPPB), niflumic acid, glibenclamide, and 
GlyH-101 were used to further characterize this conductance.
to Alexa Fluor 680 (Invitrogen), and secondary goat anti–rabbit 
immunoglobulin G conjugated to IRDye 800 (Rockland Immuno-
chemicals, Inc.). The expression of CFTR was determined by an-
tibody 5959, which is a rabbit anti–human CFTR R domain 
polyclonal antibody generated by us to the peptide IEEDSDEPL-
ERRLSLVPDSEQGE. The glyceraldehyde-3-phosphate dehydro-
genase antibody was obtained from USBiological. The fluorescence 
signal was analyzed by the Odyssey Infrared Imaging System (LI-
COR Biosciences).
Immunocytochemistry
Confluent T84 cells grown on 25-mm tissue culture inserts 
(Thermo Fisher Scientific) were fixed on ice in 3% paraformalde-
hyde solution in PBS (EM grade; Electron Microscopy Sciences). 
Cells were washed in ice-cold PBS and quenched with 50 mM 
NH4Cl in PBS for 15 min on ice. Nonspecific staining was blocked 
in PBS containing 1% BSA and 0.075% saponin for 30 min on ice. 
An anti–Epac 1 antibody (1:10) was then added for 1 h at room 
temperature, after which excess antibody was washed in 0.1% BSA 
in PBS with 0.075% saponin. The cells were then incubated with 
a goat anti–mouse secondary antibody conjugated to Alexa 568 
for an additional hour. After extensive washing of excess secondary 
antibody, cells were incubated with Hoechst 33324 (Invitrogen) 
and mounted on microscope slides. Microscopy was performed 
using an LSM 510 (Carl Zeiss, Inc.).
Activation of Ras-related protein 2 (Rap2)
Activation of Rap2 was determined by the EZ-Dectect Rap activa-
tion kit (Thermo Fisher Scientific) with slight modifications. In 
brief, T84 cells were incubated with or without FSK and 50 µM 
8-pCPT-2’-O-Me-cAMP for 20 min at 37°C. These cells were lyzed 
with 25 mM Tris/HCl, pH 7.5, 150 mM NaCl, 5 mM MgCl2, 1% 
NP-40, 1 mM DTT and 5% glycerol, 10 mM NaF, and 1 mM 
Na3VO4 in the presence of a protease inhibitor cocktail (Sigma-
Aldrich). After centrifugation at 16,000 g at 4°C for 15 min to re-
move insoluble materials, the supernatants (700 µg of protein) 
were incubated with 20 µg of glutathione-S-transferase–tagged 
RalGDS-RBD (Ras-binding domain of the Ral guanine nucleotide 
dissociation stimulator) and an Immobilized Glutathione Disc 
(resin; SwellGel) for 1 h at 4°C. The affinity-purified activated Rap 
proteins (Rap-GTP) were eluted with 50 µl SDS/PAGE sample 
buffer containing 5% 2-mercaptoethanol and analyzed by Western 
blotting with anti-Rap2 antibody.
RNA interference
Mission, the RNA interference Consortium (TRC) lentiviral 
short hairpin RNA (shRNA) constructs, which target against 
Epac1, were obtained from Sigma-Aldrich (TRCN0000047228, 
TRCN0000047230, and TRCN0000047231). Lentiviral particles 
were produced in HEK293T cells grown on 10-cm plates by co-
transfecting cells with lipofectamine 2000 with 3 µg pVSVG (ve-
sicular stomatitis virus glycoprotein), 9 µg pCMV∆R8.9, and 12 µg 
shRNA plasmids. This mixture of lipofectamine and plasmids was 
added to the cells and incubated for 16 h. Transfection medium 
was then removed and replaced with fresh culture medium. Viral 
particles were then collected in 7 ml of medium 48 h after trans-
fection. Viral supernatant was centrifuged at 1,000 rpm for 5 min 
and stored in aliquots at 80°C. For lentiviral transduction, T84 
cells were grown on 35-mm dishes to 70% confluency. On the 
day of transduction, the culture medium was replaced with 2 ml 
of fresh medium containing 2 mg/µl hexadimethrine bromide 
(Sigma-Aldrich). 1 ml of lentiviral particles was added to and in-
cubated with cells for 20 h. The lentiviral particles were then re-
moved, and the cells were replaced with fresh culture medium. 
48 h after transduction, positively transduced cells were selected 
with 10 µg/ml of puromycin-containing medium. Empty vector–
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addition (3,234 ± 117 Ω·cm2 vs. 3,044 ± 135 Ω·cm2, re-
spectively). Similarly, Gö6976, U73122, and H89 did 
not affect transepithelial resistance (not depicted).
FSK increases [Ca2+]i
We measured the change of [Ca2+]i in T84 cells upon 
FSK stimulation. The resting level of [Ca2+]i was 150 nM 
(Fig. 2 A). FSK caused a sustained elevation of [Ca2+]i 
immediately after its addition ([Ca2+]i = 42 ± 10 nM; 
P < 0.05). We then determined the source of the [Ca2+]i 
increase by measuring [Ca2+]i in the absence of extra-
cellular Ca2+ and then after the introduction of 1.8 mM 
Ca2+ to the extracellular medium. Both Ca2+ release and 
entry were observed after FSK addition (Fig. 2 B). The 
sustained rise in [Ca2+]i depended on extracellular Ca2+, 
whereas the initial rise did not. This increase in [Ca2+]i 
was blocked by preincubation with the PLC inhibitor 
U73122 (10 µM) (Fig. 2 C). Collectively, these results 
suggested that the FSK-induced [Ca2+]i rise was PLC me-
diated. The rise in [Ca2+]i further induced the entry of 
Ca2+ across the membrane. The latter fact was further 
supported by the inhibitory effect of LaCl3, a nonspe-
cific membrane Ca2+ channel blocker (Fig. S1 A). 200 µM 
LaCl3 inhibited the FSK-stimulated Cl secretion. Simi-
larly, the IP3-induced Ca2+ release inhibitor 2-APB (50 µM) 
inhibited the FSK-stimulated Cl secretion (Fig. S1 B). 
Patch clamp recording
Whole cell recordings were performed in Chinese hamster ovary 
(CHO) cells transiently transfected with a plasmid containing 
human CFTR tagged with EGFP. Cells were visualized using an 
Eclipse Fluorescent inverted microscope (Nikon). Whole cell 
currents were input into an Axopatch 200B amplifier (Axon Instru-
ments) and analyzed using PClamp 9.2 software (Axon Instru-
ments). Cells were bathed in solution containing (in mM): 140 NaCl, 
2 CaCl2, 1 MgCl2, 80 D-mannitol, and 10 HEPES, pH 7.4. The 
pipette solution consisted of (in mM): 135 CsCl, 2 MgCl2, 2 ATP, 
10 HEPES, and 0.001 free Ca2+, pH 7.4. The hypertonic bath solu-
tion was used to prevent the activation of any swelling activated 
Cl conductance.
Statistics
Results were analyzed by the statistic software Origin and pre-
sented as means ± SE of at least three independent experiments. 
Comparisons between means were performed using Student’s 
t tests. Differences among groups were determined using one-way 
ANOVA and Student-Newman-Keuls posttest. An overall P < 0.05 
was considered significant.
Online supplemental material
The supplemental material includes the effect of lanthanum chlo-
ride (LaCl3) and 2-APB on FSK-stimulated Isc in T84 cells (Fig. S1) 
and the effect of U73122 and 1,2-bis-(o-aminophenoxy)-ethane-
N,N,N’,N’-tetraacetic acid, tetraacetoxymethyl ester (BAPTA-AM) on 
vasoactive intestinal peptide (VIP)-stimulated or 8-Br-cAMP-
stimulated Cl secretion in T84 cells (Fig. S2). Fig. S3 shows 
that the Epac activator 8-pCPT-2’-O-Me-cAMP does not activate 
CFTR transiently expressed in CHO cells, which express en-
dogenous Epac1. Figs. S1–S3 are available at http://www.jgp 
.org/cgi/content/full/jgp.200910339/DC1.
R E S U LT S
PKA-independent effects of FSK-stimulated Cl secretion 
in T84 cells
We first tested whether cAMP-stimulated Cl secretion 
in T84 cells was exclusively PKA dependent. Cells were 
grown on transwell supports placed in Ussing chambers 
containing an HCO3 free Cl solution. The PKA inhib-
itor, H89 (1 µM), partially inhibited the effect of FSK 
(10 µM) (Fig. 1). Similarly, the effect of FSK was par-
tially inhibited by the conventional PKC inhibitor 
Gö6976 (5 µM), the PLC inhibitor U73122 (10 µM), or 
the intracellular Ca2+ chelator BAPTA-AM (25 µM). 
However, a high concentration of H89 (50 µM), which 
inhibits both PKA and PKC, inhibited 90% of the FSK-
stimulated Cl secretion (Hidaka et al., 1990; Davies 
et al., 2000; Lochner and Moolman, 2006). Therefore, 
we further tested whether the combination of 1 µM H89 
and other kinase inhibitors could completely inhibit the 
FSK-stimulated Cl secretion. The effects of 1 µM H89 
and 5 µM Gö6976, of 1 µM H89 and 25 µM BAPTA-AM, 
or of 1 µM H89 and 10 µM U73122 were additive. These 
results suggested that FSK-stimulated Cl secretion was 
both PKA and Ca2+ dependent, and that the Ca2+ effect 
was additive to the effect of PKA. There was no change 
in transepithelial resistance before or after BAPTA-AM 
Figure 1. Effect of protein kinase modulators and BAPTA-AM on 
FSK-stimulated Cl secretion. Cell monolayers were pretreated 
with H89, Gö6976, U73122, BAPTA-AM, H89 plus Gö6976, H89 
plus BAPTA-AM, or H89 plus U73122 for 30 min with the indi-
cated concentrations. FSK was then added. FSK-stimulated Isc for 
each condition was derived from the Isc values before and after 
the addition of FSK. Statistical comparisons between means were 
performed using Student’s t test and among means with one-way 
ANOVA and Student-Newman-Keuls posttest. *, P < 0.05; **, P < 
0.01; ***, P < 0.001 compared with FSK control group.
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However, by Western blot, Epac1 but not Epac2 pro-
tein was present (Fig. 3 B). This is consistent with the 
observation that Epac2 is predominately expressed in 
the brain and adrenal gland, whereas Epac1 has ubiq-
uitous expression (de Rooij et al., 1998; Kawasaki 
et al., 1998). We further studied the distribution of 
endogenous Epac1 in T84 cells by immunostaining 
(Fig. 3 C). Epac1 staining (red) of T84 cells was mostly 
intracellular, as shown by both the vertical XZ image 
and the horizontal XY image. A control experiment 
with only secondary antibody did not have specific 
staining (not depicted).
The results from the LaCl3 and 2-APB experiments 
demonstrated that Ca2+ release from IP3-sensitive inter-
nal stores and entry from the extracellular milieu may 
have a role in FSK-stimulated Cl secretion.
Expression of Epac in T84 cells
cAMP binds to Epac proteins and subsequently elevates 
[Ca2+]i (de Rooij et al., 1998; Kawasaki et al., 1998). 
Therefore, as part of establishing a role for Epac in FSK-
stimulated Cl secretion, we tested whether Epac mes-
sage or protein is expressed in T84 cells. Using RT-PCR, 
both Epac1 and Epac2 transcripts were detected (Fig. 3 A). 
Figure 2. Measurement of [Ca2+]i in T84 cells. (A) Cells were 
loaded with Fura2-AM at 37°C in the presence of 1.2 mM of ex-
tracellular Ca2+. After 30 min of de-esterification in the presence 
of 5 µM indomethacin, cell monolayers were used for [Ca2+]i 
measurement at room temperature in the presence of 1.8 mM 
of extracellular calcium and challenged with 10 µM FSK as indi-
cated (n = 3). (B) [Ca2+]i was measured in cells challenged with 
10 µM FSK initially in the absence of extracellular Ca2+, followed 
by reintroduction of 1.8 mM of extracellular Ca2+. (C) [Ca2+]i was 
measured in cells in the absence or presence of extracellular Ca2+ 
by preincubating with 10 µM U73122 during the 30 min of de-
esterification. FSK was then added (n = 3).
Figure 3. Expression and localization of Epac in T84 cells. 
(A) Epac1 and Epac2 message was amplified by RT-PCR from T84 
cell total RNA (n = 6). (B) Epac1 (105 kD) and Epac 2 (100 kD) 
expression in total cell lysate of T84 was analyzed by Western blot. 
Total rat cerebellum (RC) lysate was used as positive control. A 
representative blot is shown (n = 5). (C) T84 cells were stained 
with anti-Epac1-70 (red), nucleus with Hoechst (blue), and apical 
surface with wheat germ agglutinin (green) as described in Ma-
terials and methods. Vertical (XZ) and horizontal (XY) confocal 
microscopy sections showed the subcellular distribution of Epac1 
in T84 cells. AP, apical side; BL, basolateral side. Images shown 
are representative of three similar experiments.
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Epac subsequently led to activation of Rap2 and eleva-
tion of [Ca2+]i, the latter event caused by selective acti-
vation of Epac with 8-pCPT-2’-O-Me-cAMP, leading to a 
rise of [Ca2+]i ([Ca2+]i = 45 ± 7 nM; n = 3) (Fig. 5 B).
Effect of Epac on apical Cl conductance
Because Cl secretion involves the coordinated func-
tions of apical Cl channels and the basolateral mem-
brane transporters, such as Na/K/ATPase, Na+/K+/2Cl, 
and K channels, and the effect of Epac on Cl secretion 
appears to be moderate, we addressed whether Epac 
has any effect on apical Cl channels and whether this 
effect is enhanced in cells with the basolateral mem-
brane permeabilized. ICl was measured in T84 monolay-
ers treated with 50 µg/ml nystatin on the basolateral 
membrane. The permeabilized cells were exposed to a 
basolateral to apical Cl gradient (Mun et al., 1998). 
Treatment with 10 µM FSK led to a brisk and sustained 
increase in ICl, which represented an activation of apical 
chloride channels (Fig. 6 A). After the maximal effect 
of FSK was obtained, the addition of 8-pCPT-2’-O-Me-
cAMP had no additional effect on Isc (not depicted). 
The FSK effect was partially inhibited by BAPTA-AM 
(Fig. 6 A). 8-pCPT-2’-O-Me-cAMP also increased apical 
ICl in basolaterally permeabilized cells. In contrast to 
FSK, the 8-pCPT-2’-O-Me-cAMP–stimulated apical ICl 
was completely inhibited by BAPTA-AM (Fig. 6 B).
Effect of BAPTA and U73122 on VIP- and 8-Br-cAMP–
stimulated Cl secretion in T84 cells
VIP acts through a G protein–coupled receptor that ac-
tivates Gs/adenylate cyclase to increase intracellular 
cAMP. The cAMP analogue 8-Br-cAMP activates PKA 
and possibly Epac as well (de Rooij et al., 1998; Kawasaki 
et al., 1998). We tested whether these two agents stimu-
lated Cl secretion in a manner similar to FSK. As 
shown in Fig. S2 A, BAPTA-AM and U73122 significantly 
Role of Epac in FSK-stimulated Cl secretion in T84 cells
To establish a link from cAMP to PLC/[Ca2+]i/PKC sig-
naling and to support a role for Epac in Cl secretion, 
we determined whether 8-pCPT-2’-O-Me-cAMP, an Epac 
agonist, could stimulate Cl secretion in T84 cells. As 
shown in Fig. 4 A, 50 µM 8-pCPT-2’-O-Me-cAMP stimu-
lated Cl secretion. 8-pCPT-2’-O-Me-cAMP had been 
shown to selectively stimulate Epac at 50–200 µM (Kang 
et al., 2003; Holz, 2004; Yip, 2006). We found 100– 
200 µM 8-pCPT-2’-O-Me-cAMP did not further enhance 
Cl secretion in T84 cells (not depicted), suggesting that 
50 µM 8-pCPT-2’-O-Me-cAMP already produced a maxi-
mal effect. This increase in Isc was completely blocked by 
pretreatment of the cells with 25 µM BAPTA-AM, but 
not with 1 µM H89. Therefore, [Ca2+]i, but not PKA, 
mediated the effect of 8-pCPT-2’-O-Me-cAMP. We hy-
pothesized that if the Epac/PLC/[Ca2+]i/PKC pathway 
contributed to the PKA-independent component of 
FSK-stimulated Cl secretion, the combined effects of 
PKA and Epac on Cl secretion in T84 cells would be 
additive. As shown in Fig. 4 B, the PKA agonist Sp-8-
pCPT-cAMP (20 µM) (Christensen et al., 2003) stimulated 
Cl secretion. Gradual increases in the concentration of 
Sp-8-pCPT-cAMP to 100 µM did not further stimulate 
Cl secretion (not depicted). However, the addition of 
the Epac activator (50 µM) further stimulated Cl secre-
tion. The stimulatory effect of 20 µM Sp-8-pCPT-cAMP 
and 50 µM 8-pCPT-2’-O-Me-cAMP on Cl secretion 
was additive.
We tested whether 10 µM FSK or 50 µM 8-pCPT-2’-O-
Me-cAMP was capable of activating Rap2 in T84 cells 
because activation of Rap2 leads to the activation of 
PLC and increased [Ca2+]i (Evellin et al., 2002). As 
shown in Fig. 5 A, a 20-min treatment of either FSK or 
8-pCPT-2’-O-Me-cAMP increased the amount of GTP-
Rap2. This result further suggested that Epac was activated 
by FSK or 8-pCPT-2’-O-Me-cAMP, and that activation of 
Figure 4. Direct activation of Epac 
with 8-pCPT-2’-O-Me-cAMP–stimu-
lated Cl secretion in T84 cells. 
(A) 50 µM 8-pCPT-2’-O-Me-cAMP 
was added to the basolateral mem-
brane of control cells or cells pre-
incubated with 1 µM H89 or 25 µM 
BAPTA-AM for 30 min. 8-pCPT-2’-
O-Me-cAMP–stimulated Isc was de-
rived from the Isc values before and 
after the addition of 8-pCPT-2’-O-
Me-cAMP. Values are means ± SEM 
(n = 5). Statistical comparisons be-
tween means were performed using 
Student’s t test. NS, not significant. 
(B) Additive effects of Sp-8-pCPT-
cAMP and 8-pCPT-2’-O-Me-cAMP 
on Cl secretion in T84 cells. 20 µM Sp-8-pCPT-cAMP was added to the basolateral membrane. This induced a sustained Cl secretion. 
50 µM 8-pCPT-2’-O-Me-cAMP was subsequently added, and this caused a further increase in Isc. Values are means ± SE (n = 6). The inset 
shows the individual effect of 20 µM Sp-CPT-cAMP and 50 µM 8-pCPT-2’-O-Me-cAMP and their additive effect on Cl secretion in T84 
cells. Statistical comparisons between means were performed using Student’s t test.
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was used to silence Epac1 protein expression in T84 
cells. We used three different TRC shRNA constructs, 
which had not previously been experimentally validated 
(as described in Materials and methods). Lentiviral par-
ticles were prepared from each shRNA construct and 
transduced into T84 cells. Cells resistant to puromycin 
were selected and characterized by Western blot. Of the 
three shRNA constructs tested, only the constructs 228 
reduced the VIP (100 nM) -stimulated Cl secretion. 
Similarly, BAPTA-AM and U73122 also inhibited 8-Br-
cAMP (100 µM) -stimulated Cl secretion (Fig. S2 B). 
These findings suggested that a rise of [Ca2+]i is involved 
in G protein–coupled receptor–mediated and the cAMP-
dependent process of Cl secretion in T84 cells.
Role of Epac in FSK-stimulated net ion transport  
in mouse ileum
To determine whether the stimulation of Cl secretion 
by Epac1 is a general mechanism of regulating intestinal 
Cl secretion, we determined that Epac1 was expressed 
in different segments of mouse intestine, including duo-
denum, jejunum, ileum, and colon, suggesting that this 
pathway could be activated along the intestine (Fig. 7 A). 
8-pCPT-2’-O-Me-cAMP stimulated net ion transport in 
mouse ileum, and this was not inhibited by 1 µM H89 but 
was inhibited by BAPTA-AM treatment (Fig. 7 B). The 
8-pCPT-2’-O-Me-cAMP–stimulated ICl in mouse ileum, with 
the basolateral membrane permeabilized with nystatin, 
was not inhibited by the CFTRinh-172 (Fig. 7 C).
Epac1 silencing in T84 cells
To further establish the role of Epac1 in FSK-stimulated 
Cl secretion, lentivirus containing shRNA against Epac1 
Figure 5. Activation of Rap2 by FSK and 8-pCPT-2’-O-Me-cAMP 
in T84 cells. (A) Cells were stimulated for 20 min without (con-
trol) or with either 10 µM FSK or 50 µM 8-pCPT-2’-O-Me-cAMP, 
followed by extraction of GTP-loaded Rap2 with glutathione-S-
transferase-RALGDS-RBD fusion protein. Samples were analyzed 
by Western blotting with an anti-Rap2 antibody. A representative 
Western blot of three experiments is shown. (B) 8-pCPT-2’-O-Me-
cAMP elevated [Ca2+]i in T84 cells. Cells were loaded with Fura2-
AM at 37°C in the presence of extracellular Ca2+. After 30 min 
of de-esterification in the presence of 2 µM indomethacin, cell 
monolayers were subjected to [Ca2+]i measurement at room tem-
perature in the presence of 1.8 mM of extracellular Ca2+ and chal-
lenged with 50 µM 8-pCPT-2’-O-Me-cAMP as indicated (n = 3).
Figure 6. Effect of FSK and 8-pCPT-2’-O’-Me-cAMP on apical Cl 
conductance in T84 cells permeabilized by nystatin on the baso-
lateral membrane. Cells were equilibrated with Cl free/high K+ 
buffer. After equilibration, the basolateral solution was replaced 
with a high Cl/high K+ solution, and this imposed a basolateral 
to apical Cl gradient. When the steady state was reached, 50 µg/ml 
nystatin was added to permeabilize the basolateral membrane. 
After the basal ICl subsided, 10 µM FSK (A) or 50 µM 8-pCPT-
2’-O-Me-cAMP (B) was added to the permeabilized basolateral 
membrane. These induced a robust increase of ICl. To prevent the 
elevation of [Ca2+]i, cells were incubated with 25 µM BAPTA-AM 
for 30 min before the addition of FSK or 8-pCPT-2’-O-Me-cAMP. 
The FSK effect was partially inhibited by BAPTA-AM (A; inset). 
In contrast, 8-pCPT-2’-O-Me-cAMP–stimulated apical Cl conduc-
tance was completely inhibited by BAPTA-AM (B; inset). A repre-
sentative tracing is shown for each experiment. The increase in 
ICl was derived from the ICl value before and after the addition of 
FSK (n = 3) or 8-pCPT-2’-O-Me-cAMP (n = 5). Values are means ± 
SEM. Statistical comparisons between means were performed us-
ing Student’s t test. **, P < 0.01; ***, P < 0.001 compared with 
control group.
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(referring to the last three digits of the TRC number) 
and 231 were able to reduce the expression of Epac1 in 
T84 cells by 89 and 76%, respectively, as determined by 
Western blot densitometry. However, the construct 230 
failed to silence Epac1 (Fig. 8 A). There was no change 
in the expression of CFTR protein between the wild-type 
cells, vector-transduced cells, and cells transduced 
with putative Epac1 shRNA constructs. The functional 
consequence of Epac1 silencing with respect to FSK-
stimulated Cl secretion was tested using these cell 
lines. As shown in Fig. 8 B, the Epac1KDT84cst228 
and Epac1KDT84cst231 cells exhibited only 43–50% of 
FSK-stimulated Cl secretion compared with wild-type 
and vector-transduced cells. In contrast, the Epac1K-
DT84cst230 cells having the shRNA construct 230 that 
failed to silence Epac1 protein responded to FSK with a 
similar magnitude of Cl secretion as wild-type and vec-
tor-transduced cells. FSK-stimulated Cl secretion in 
Epac1KDT84cst228 cells was inhibited by 1 µM H89, but 
not by U73122 and BAPTA-AM (Fig. 8 C), confirming 
that in the absence of Epac1, FSK-stimulated Cl secretion 
was completely PKA dependent. FSK and the Epac acti-
vator also failed to elevate [Ca2+]i in these Epac-silenced 
cells (not depicted).
Epac-mediated chloride currents are not caused by CFTR
To further confirm that Epac1-mediated Cl secretion 
in T84 cells was not due to CFTR, we transiently trans-
fected CHO cells that express endogenous Epac1 with a 
CFTR construct. Then, Cl currents were recorded in 
the whole cell configuration (Lorenowicz et al., 2006). 
As shown in Fig. S3 (A–C), 100 µM 8-pCPT-2’-O-Me-
cAMP had no effect on current amplitudes (233.9 ± 
65.2 pA vs. 203.7 ± 58.3 pA; P = 0.29), whereas subse-
quent application of a CFTR-stimulating cocktail of 
100 µM cpt-cAMP plus 10 µM FSK activated large, linear 
CFTR currents (1,334.7 ± 250.5 pA; P ≤ 0.005) (Fig. S3, 
A and B). The cpt-cAMP/FSK–activated currents were 
inhibited by the application of 10 µM CFTR inh-172 
(I(pA) = 392.7 ± 149.7; P ≤ 0.01). The cpt-cAMP/FSK–
activated Cl currents and the inhibition by 10 µM 
CFTRinh-172 demonstrated that the Cl conductance 
stimulated by cpt-cAMP/FSK was specifically a CFTR-
mediated conductance.
Biophysical properties of the Epac-stimulated Icl
We characterized the biophysical properties of the se-
cretory currents activated by Epac. We took advantage 
of the basolateral-permeabilized membrane protocol to 
isolate the channel currents at the apical surface, allow-
ing a description of the I-V relationship and measure-
ment of the reversal potential. In Fig. 9 A, we plotted 
the current against the clamped, stepped voltages of 
T84 monolayers with permeabilized basolateral mem-
branes in the presence of 50 µM 8-pCPT-2’-O-Me-cAMP. 
The recorded currents had significant inward rectification 
Figure 7. Western blot of total lysates from mouse intestinal mu-
cosal scrapings. (A) Epac1 is expressed in different segments of 
the intestine, including duodenum (MD), jejunum (MJ), ileum 
(MI), and colon (MC; n = 3). (B) Activation of Epac with 8-pCPT-
2’-O-Me-cAMP–stimulated net ion transport in mouse ileal sheets 
(ex vivo). 100 µM 8-pCPT-2’-O-Me-cAMP was added to the baso-
lateral membrane of control mouse ileum or ileum preincubated 
with 1 µM H89 or 25 µM BAPTA-AM for 30 min. The 8-pCPT-
2’-O-Me-cAMP–stimulated Isc was calculated from the Isc values 
before and after the addition of 8-pCPT-2’-O-Me-cAMP. H89 
had no effect on 8-pCPT-2’-O-Me-cAMP–stimulated Isc, whereas 
BAPTA-AM inhibited the current. Values are means ± SEM (n = 5). 
(C) Ex vivo apical ICl measurement in mouse ileum permeabilized 
by nystatin on the serosal side. Tissues were equilibrated with Cl 
free/high K+ buffer. After equilibration, the basolateral solution 
was replaced with a high Cl/high K+ solution, which imposed 
a basolateral to apical Cl gradient. When the steady state was 
reached, 50 µg/ml nystatin was added to permeabilize the serosal 
membrane. 8-pCPT-2-O-Me-cAMP induced a robust increase of 
ICl, which was insensitive to the CFTRinh-172. Data are expressed 
as the mean ± SE (n > 3). **, P = 0.01 compared with the DMSO 
control. Statistical comparisons between means were performed 
using Student’s t test. NS, not significant.
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with a reversal potential of 39 mV. The only non- 
balanced ion/anion was Cl with a Nernst potential of 
90.0 mV, somewhat dissimilar from that of the Nerst po-
tential of the Epac-stimulated current. This discrepancy 
might be due, in part, to the small amplitude of the 
recorded current, suggesting that the Epac activator 
did not fully stimulate the Cl current. This drawback, 
along with our inability to use large amounts of the 
8-pCPT-2’-O-Me-cAMP compound because of its scarcity, 
led us to rely on FSK activation of the Epac currents 
with and without CFTRinh-172. Fig. 9 B reveals that 
outward FSK-activated currents (black squares) had large 
amplitudes and were somewhat linear, but the apical 
application of the CFTRinh-172 decreased the current 
amplitude and changed the shape of the I-V relation-
ship. The FSK plus CFTRinh-172 currents were inwardly 
rectifying, similar to the currents activated by 8-pCPT-
2’-O-Me-cAMP (Fig. 9 B). In either case, it is important 
to note that K+ ions at nonzero potentials could possi-
bly be contributing to the I-V shape through yet un-
known apical K+ channels, although unlikely in secretory 
T84 cells.
We next measured the reversal potentials for the FSK-
activated currents with or without the CFTRinh-172 
and with or without a steep basal to apical Cl gradient 
(Fig. 9 C). The FSK-activated chloride current had a re-
versal potential of 76 mV (Erev Cl = 90.0 mV), indicating 
that the largest apical ion conductance was a Cl conduc-
tance (all other permeant ions had a zero Nernst poten-
tial), a conductance that had been shown many times to 
be largely mediated by CFTR. The application of the 
CFTRinh-172 shifted the reversal potential to 52 mV. 
The shift represented the loss of the Cl conductance 
through CFTR channels on the apical membrane, suggest-
ing that the remaining current was the Epac-activated 
Cl conductance and a sizable but unchanging leak cur-
rent (Eleak = 0 mV). Balancing Cl on either side of the 
apical membrane (new ECl = 0 mV) shifted the reversal 
potential to 6 mV, demonstrating the Epac-mediated 
current was a Cl current. Using Fick’s first law, we next 
calculated the absolute permeabilities of Cl: PCl = JCl 
(mmol/cm2*s)/([Cl in]  [Cl out])(mmol/cm3), 
where JCl = (ICl at 0 mv)/Faraday constant. The calcu-
lated PCl for the FSK-activated currents was 16.04 × 106, 
very similar to that reported previously (13.1 ± 1.8 × 106; 
Huflejt et al., 1994) also in T84 cells. The CFTRinh-172-
inhibited current had a PCl = 8.61 × 106, a sizable Cl 
permeability and larger than that measured for carba-
chol-activated chloride currents (Huflejt et al., 1994). 
Finally, we investigated the permeability of the Epac-
mediated Cl currents (Fig. 9 D). We substituted either I 
or Br on the basolateral side and measured the Isc with 
Figure 8. Epac1 silencing in T84 cells. (A) Western blot analysis 
of Epac1 expression in total cell lysate of wild-type T84 (T84-WT), 
vector control, and Epac1 shRNA-transduced cells (EpacK-
DT84CST228, EpacKDT84CST230, and EpacKDT84CST231). 
The amount of Epac1 protein was decreased by 76% in EpacK-
DT84CST228 and 89% in EpacKDT84CST231 cells, as determined 
by densitometry and normalized to glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) (n = 4). EpacKDT84CST230 expressed 
the same amount of Epac1 protein as wild-type T84 cell and thus 
was used as a negative control for silenced cells. There was no 
change in CFTR expression. (B). EpacKDT84CST228 and EpacK-
DT84CST231 cells responded to FSK with a stimulated Cl se-
cretion having only half the magnitude as that of wild-type and 
vector-transduced cells (n = 5). In contrast, EpacKDT84CST230 
responded to FSK with a stimulated Cl secretion similar to wild-
type cells. Statistical comparisons among means were performed 
with one-way ANOVA and Student-Newman-Keuls posttest. **, 
P < 0.01 compared with T84WT. (C) FSK-stimulated Cl secre-
tion in EpacKDT84CST228 cells was inhibited by 1 µM H89, but 
not by U73122 and BAPTA (n = 5). Values are means ± SEM 
(µA/cm2). Statistical comparisons between means were performed 
using Student’s t test. NS, not significant. **, P < 0.01 compared 
with control.
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channel (CaCC), 100 µM zinc (Zn2+), and 1 mM cadmium 
chloride (Cd2+), which inhibits the voltage-gated Cl 
channel isoform 2 (ClC2). The lack of effect of these in-
hibitors suggested that CFTR, CaCC, and ClC2 were not 
responsible for Epac-mediated Cl secretion (Fig. 10 A). 
To ascertain that cAMP-stimulated Cl secretion occurs 
through two different Cl channels, we measured ICl in 
basolaterally permeabilized T84 cells in the presence of 
either CFTRinh-172 plus DIDS or CFTRinh-172 plus 
NPPB. Fig. 10 B shows that the combined effect of 
CFTRinh-172 along with either DIDS or NPPB was greater 
compared with CFTRinh-172 alone. Thus, these two in-
hibitors partially inhibited a component of the cAMP-
stimulated Cl secretion in intact T84 cells (not depicted; 
Merlin et al., 1998). Interestingly, we have found that the 
cAMP-stimulated apical ICl was completely inhibited by 
basolateral-permeabilized membranes. We found that 
Cl was more permeable than either I or Br, with a 
selectivity sequence of Cl>Br>I and relative permea-
bilities of PCl/PCl = 1, PBr-/PCl = 0.9, and PI-/PCl = 
0.6. The anion permeability through nystatin pores is 
based on hydrated ion radius (Cass et al., 1970), and 
Cl, Br, and I have essentially the same hydrated radius 
(3.32, 3.30, and 3.31 Å) (Conway, 1981) and thus pre-
dictive similar nystatin permeabilities.
To identify blockers of the apical Cl conductance in-
volved in the Epac-mediated Cl secretion, the 8-pCPT-
2’-O-Me-cAMP–stimulated ICl was challenged with 5 µM 
of the CFTRinh-172 (Ma et al., 2002; Factor et al., 2007) 
or 100 µM glibenclamide (Schultz et al., 1996; Sheppard 
and Robinson, 1997). Other inhibitors added were 100 µM 
niflumic acid, which inhibits the calcium-activated Cl 
Figure 9. Biophysical characterization of FSK-activated, Epac-mediated Isc current. (A) I-V plot of the 8-pCPT-2’-O-Me-cAMP–stimulated 
current of nystatin-permeabilized T84 cells with basal to apical (145 mM) Cl gradient. Currents are portrayed using the physiological 
convention, where membrane potential (V) = basolateral (V1)  apical (V2), possible here because the basolateral membrane is per-
meabilized to Cl. Data are means ± SEM (n = 6). See Materials and methods for complete description of this experiment. (B) I-V plot 
of current recordings of nystatin-permeabilized T84 cells treated with 10 µM FSK (black squares) or 10 µM FSK plus 5 µM CFTRinh-172 
(red circles) under symmetrical (basal/apical) Cl gradient (data are means ± SEM; n = 2–8). (C) Reversal potential measurements from 
voltage-clamped basolaterally permeabilized T84 cells: I-V relationships of outward currents with linear fits for apical membranes treated 
with FSK (black squares; R2 = 0.989.31 and Erev = 76; n = 5), FSK plus CFTRinh-172 (red triangles; R2 = 0.99942 and Erev = 52; n = 5), 
or FSK plus CFTRinh-172 plus symmetrical Cl (blue circles; R2 = 0.98337 and Erev = 6; n = 3). (D)Halide selectivity: representative Isc 
recordings from permeabilized T84 cells treated with FSK plus CFTRinh-172. The apical and basolateral sides were bathed with a Cl-
containing solution, an equal molar of Br or I was substituted on the basal side, and the Isc was recorded.
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D I S C U S S I O N
PKA has been regarded as the major and only effector 
of cAMP in modulating CFTR function in the apical 
membrane of intestinal and airway cells (Vajanaphanich 
et al., 1995; Barrett, 2000; Huang et al., 2000; Boucher, 
2007; Thelin and Boucher, 2007). However, Merlin et al. 
(1998) showed that FSK is capable of elevating [Ca2+]i 
in intestinal T84 cells, in addition to increasing intra-
cellular cAMP concentrations (Merlin et al., 1998; Holz, 
2004). This suggests that [Ca2+]i might also be involved 
in intestinal Cl secretion as a consequence of FSK stim-
ulation. The mechanism by which FSK elevates [Ca2+]i 
has not been clear. Epac is a cAMP-binding protein that 
transduces cAMP signaling into increases in [Ca2+]i 
(Schmidt et al., 2001). Because both PKA and Epac are 
broadly expressed in many tissues and are activated by 
binding to cAMP with similar affinity (de Rooij et al., 
1998; Kawasaki et al., 1998; Schmidt et al., 2001), an in-
crease in intracellular cAMP will likely lead to activation 
of both PKA and Epac.
Our data showed that both PKA and PLC/[Ca2+]i/
PKC pathways were involved in FSK-stimulated Cl se-
cretion and their effects were additive. It was shown that 
H89 inhibits PKA in nanometer concentrations (IC50 = 
48 nM), whereas at micrometer (IC50 = 14 µM) concen-
trations, it inhibits PKC as well (Chijiwa et al., 1990; 
Hidaka et al., 1990; Hidaka and Kobayashi, 1992; Muroi 
and Suzuki, 1993; Davies et al., 2000; Lochner and 
Moolman, 2006). Thus, 1 µM H89 has been used to se-
lectively inhibit PKA, for example, in studies demon-
strating adenosine-induced PKA activation of K+ channel 
currents in arterial myocytes (Kleppisch and Nelson, 
1995) and for distinguishing between PKA-dependent 
and -independent apical exocytosis of aquaporin-2 in 
renal inner medullary collecting duct cells (Yip, 2006). 
In our studies, 1 µM H89 was used to inhibit the PKA-
dependent component of FSK-stimulated Cl secretion. 
It was found that 1 µM H89 only partially inhibited FSK-
stimulated Cl secretion, which was also partially inhib-
ited by U73122, Gö6976, and BAPTA-AM. The effects of 
H89 and Gö6976, of H89 and BAPTA-AM, or of H89 
and U73122 were additive. These results suggested the 
presence of a Ca2+-sensitive, PKA-independent compo-
nent of Cl secretion. The cAMP secretagogue, VIP, and 
8-Br-cAMP had the same effect as FSK. Furthermore, 
FSK increased [Ca2+]i in T84 cells. Thus, our observa-
tion confirmed the finding of Merlin et al. (1998), that 
FSK induced a moderate increase in [Ca2+]i. It is worth-
while to note that FSK/cAMP is also found to increase 
[Ca2+]i in chicken enterocytes (Semrad and Chang, 
1987) and intestinal HT29 cells (Denning et al., 1994). 
In addition, apical adenosine, acting via cAMP, has re-
cently been shown to regulate basolateral Ca2+-activated 
K channels in Calu-3 cells via PLC- and Ca2+-dependent 
signaling pathways (Wang et al., 2008). FSK/cAMP is 
GlyH-101(Fig. 10 C), a previously considered CFTR 
blocker but now known to also block CaCCs (Hartzell 
et al., 2009).
Figure 10. Pharmacological profile of the Cl channel blockers 
in basolaterally permeabilized T84 cells. (A) Effect of channel 
blockers on 8-pCPT-2’-O-Me-cAMP–stimulated apical Cl conduc-
tance. 5 µM CFTRinh-172, 100 µM glibenclamide, 100 µM niflu-
mic acid, or 1 mM cadmium chloride (CdCl2) was applied after 
maximum Cl currents in the presence of 50 µM 8-pCPT-2’-O- 
Me-cAMP (data are mean ± SEM; n = 3–5). NS, not significant. 
(B) Effects of DIDS or NPPB on FSK-stimulated ICl in the presence 
of CFTRinh-172. Representative traces showing that 100 µM DIDS 
and 100 µM NPPB inhibited the FSK-stimulated, CFTRinh-172–
insensitive Cl current (Epac mediated) in basolaterally permea-
bilized T84 cells. (C) Effect of 10 µM GlyH-101 on FSK-stimulated 
ICl in basolaterally permeabilized T84 cells. Representative trace 
showing that GlyH-101 completely inhibited FSK-stimulated api-
cal ICl (n = 3).
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et al., 1995), we challenged T84 cells with the addition 
of 8-pCPT-2’-O-Me-cAMP followed by Sp-8-pCPT-cAMP, 
and the same result was obtained (not depicted). In ad-
dition, when the maximal effect of FSK alone was ob-
tained, the Epac pathway appeared to have been fully 
activated, as there was no additional effect on Isc by Epac 
stimulator addition. To reconcile the synergistic effect 
on Cl secretion by the combined addition of cAMP 
and carbachol and the additive effect of Sp-8-pCPT-
cAMP and the Epac activator, it should be pointed out 
that the Ca2+-elevating agent carbachol acts through the 
Gq-coupled receptor. Different pools of intracellular 
Ca2+ might have been mobilized by Epac and carbachol, 
and consequently, their downstream signaling events 
and effects on Cl secretion would be predicted to be 
different. In addition, the effect of carbachol on Cl se-
cretion is transient (Vajanaphanich et al., 1995; Barrett, 
2008), whereas that of Epac is sustained. Carbachol ele-
vates [Ca2+]i by 350–450 nM (Vajanaphanich et al., 1995), 
whereas the effect of Epac on [Ca2+]i is 50 nM (Fig. 5 B). 
This moderate elevation of [Ca2+]i and its source from a 
pool probably distinct from that sensitive to carbachol 
either does not or is insufficient to fully activate Ca-
dependent basolateral K+ channels, which might provide 
additional driving force for Cl to exit across the apical 
membrane. Therefore, carbachol exerts a synergistic 
effect with cAMP on Cl secretion, whereas the Epac ef-
fect is additive to Sp-8-pCPT-cAMP. In fact, the basolateral 
membrane also limits the effect of Epac alone on Cl 
secretion. In intact cells, the Epac agonist only had a 
modest effect. When the basolateral membrane was per-
meabilized, the Epac agonist had a more enhanced ef-
fect on apical Cl conductance, which was 40–50% of 
that produced by FSK (compare Fig. 6, A with B). This 
means that fully half of the FSK-stimulated Cl conduc-
tance at the apical membrane was not due to CFTR. A 
working model of FSK stimulation of Cl secretion in 
T84 cells is depicted in Fig. 11. This model demon-
strates that activation of adenylate cyclase by FSK results 
in formation of cAMP. Because the effect of FSK could 
be reproduced by 8-Br-cAMP and by VIP, and the effect 
of Epac was PKA independent, these findings suggest 
that PKA and Epac1 are independent downstream ef-
fectors of cAMP. Epac1 activates Rap2, which then leads 
to an increase in [Ca2+]i. PLC is activated by small 
GTPases, such as Ras and Rho(Schmidt et al., 2001), 
and the involvement of PLC was indicated by the eleva-
tion of [Ca2+]i by FSK, which was completely blunted by 
U73122, and that FSK-stimulated Cl secretion was 
partially blunted by U73122. Because FSK-stimulated 
Cl secretion was inhibited by Gö6976, which selectively 
inhibits the Ca2+-sensitive conventional PKC isoforms 
PKC, PKC, and PKC, candidate PKC isoforms are 
involved in secretion (Doolen and Zahniser, 2002). We 
conclude from all of this that the final outcome of Epac 
activation is a Cl secretion through a yet-to-be identified 
also able to mobilize [Ca2+]i in inner medullary collect-
ing duct cells(Yip, 2006), rat cardiac myocytes (Pereira 
et al., 2007), and HEK293 cells(Schmidt et al., 2001) 
and increases Ca2+-induced Ca2+ release in pancreatic 
 cells (Dyachok et al., 2004; Dyachok and Gylfe, 2004; 
Holz, 2004). These studies also support the link between 
cAMP with Ca2+ mobilization as observed in our studies.
Upon binding cAMP, Epac activates Rap GTPases, 
which stimulate PLC and mobilize [Ca2+] from intra-
cellular stores (Schmidt et al., 2001). PLC is involved in 
FSK, VIP, or 8-Br-cAMP increases in Cl conductance 
because the conductance is partially inhibited by the 
PLC inhibitor, U73122. The effect of Epac and FSK on 
[Ca2+]i is completely abolished by U73122. Among vari-
ous PLC isoforms, PLC is an effector of Ras. Associa-
tion of Ras and Rho proteins with the Ras-binding 
domains of PLC activates the phospholipase activity of 
the enzyme (Maly et al., 2007). The direct involvement 
of Epac in Cl secretion was indicated by the use of the 
Epac activator, which activates Rap2, elevates [Ca2+]i, 
and stimulates Cl secretion. 8-pCPT-2’-O-Me-cAMP also 
stimulated net ion transport in mouse ileum indepen-
dently of PKA. Furthermore, other evidence confirm-
ing the role of the Epac pathway after increases in 
cAMP came from our studies on Epac1KDT84cst228 and 
Epac1KDT84cst231 cells that exhibited >75% reduc-
tion in expression of Epac1 protein and responded to 
FSK-stimulated Cl secretion with only half the magni-
tude as that of wild-type and vector-transduced cells. 
Most importantly, this reduction in Isc response to FSK 
was not due to a change in CFTR protein. Our studies 
also found that the construct TRCN000047230 failed 
to silence Epac1; therefore, Epac1KDT84cst230 cells 
were considered a negative control in addition to the 
vector-transduced cells. FSK-stimulated Cl secretion in 
Epac1KDT84cst228 cells was completely dependent on 
PKA, no longer dependent on PLC, and insensitive to 
BAPTA-AM treatment. Thus, these studies provide 
compelling evidence that Epac contributed to the FSK-
stimulated Cl secretion.
Previous studies by Vajanaphanich et al. (1995) dem-
onstrated a synergistic Cl secretion in T84 cells in re-
sponse to simultaneous elevation of cAMP and Ca2+. 
Based on the model of intestinal Cl secretion, which 
involves basolateral Na+/K+/2Cl cotransporter and K+ 
channels as well as apical Cl channels, possible mecha-
nisms of synergism include cooperative effects of cAMP 
and Ca2+ on the apical Cl conductance and/or stim-
ulated opening of Ca2+-regulated basolateral K channel 
(Anderson and Welsh, 1991; Reenstra, 1993; Barrett and 
Keely, 2000). Therefore, we tested whether sequential 
addition of Sp-8-pCPT-cAMP and 8-pCPT-2’-O-Me-cAMP 
would result in synergistic response to Cl secretion. Our 
result suggested that the effects of Sp-8-pCPT-cAMP and 
8-pCPT-2’-O-Me-cAMP were additive. Because the order 
of addition might affect the outcome (Vajanaphanich 
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commonly reported for CFTR is Br>Cl>I (Riordan, 
1993). CFTR channels also have a single-channel con-
ductance of 4–10 pS (Fuller and Benos, 2000). In our 
study, when CHO cells that have endogenous Epac 
expression(Lorenowicz et al., 2006) were transiently 
transfected with a plasmid containing human CFTR, 
8-pCPT-2’-O-Me-cAMP did not increase the current 
amplitude, whereas subsequent application of a CFTR-
stimulating cocktail of 100 µM cpt-cAMP plus 10 µM FSK 
activated large, linear currents (Fig. S3). The cpt-cAMP/
FSK–activated currents were inhibited by the application 
of 10 µM CFTRinh-172, demonstrating that the Cl con-
ductance stimulated by cpt-cAMP/FSK was a CFTR-medi-
ated conductance. Therefore, it appears that in cells 
containing CFTR, but not the complete complement of 
endogenous Cl channels found in intestinal epithelial 
cells, 8-pCPT-2’-O-Me-cAMP fails to activate a Cl con-
ductance, strongly supporting our hypothesis that Epac1 
does not activate CFTR but another yet unidentified Cl 
channel. The involvement of a non-CFTR Cl channel 
was strongly indicated by the observation that a specific 
CFTR channel blocker, CFTRinh-172, partially inhibited 
the cAMP-stimulated Cl secretion but was not able to in-
hibit 8-pCPT-2’-O-Me-cAMP–stimulated apical Cl con-
ductance in T84 cells, and that 8-pCPT-2’-O-Me-cAMP 
itself was unable to activate a CFTR current.
In the past, there were conflicting results about the 
presence of apical Ca2+-activated Cl channels in T84 
cells. When nystatin was used to permeabilize basolat-
eral membranes of T84 cells, there was no evidence of 
Ca2+-stimulated Icls (Anderson and Welsh, 1991; Reenstra, 
1993). However, other studies showed that carbachol or 
thapsigargin increased a Cl conductance in T84 cells 
(Barrett et al., 1998; Merlin et al., 1998). The presence 
of apical Ca2+-sensitive Cl conductances in T84 cells 
was further supported by whole cell patch clamp studies 
in which Cliff and Frizzell (1990) showed cAMP- and 
Ca2+-stimulated different Cl conductances. Merlin et al. 
(1998) showed similar results that cAMP increased at least 
two current components, one of which has features in 
common with that elicited by Ca2+-elevating agents. Ca2+-
activated Cl channels generally display I>Br>Cl 
permeability sequence (Evans and Marty, 1986). The 
molecular identity of the proteins underlying the ubiq-
uitously expressed Ca2+-dependent anion conductance 
has remained elusive. CaCC conductances are generally 
inhibited by DIDS and niflumic acid but have varying 
responses to NPPB. These channels are also diverse in 
their biophysical properties, for example, with single-
channel conductances ranging from 1 to 70 pS and recti-
fication ranging from strong outward to relatively linear 
I-V relationships (Marty et al., 1984; Klöckner, 1993). 
On the other hand, the ubiquitously expressed ClC2, 
also found to mediate Cl secretion in many epithelia, 
including Caco-2 and T84 monolayers (Gyömörey et al., 
channel. This pathway of enhanced Cl secretion, inde-
pendent of the CFTR channel, might be useful in treat-
ing cystic fibrosis where the CFTR channel is defective. 
Thus, Epac1 transduces cAMP signaling into Ca2+ sig-
naling, providing an additional pathway to manifest the 
effects of cAMP on intestinal Cl secretion.
To compare the Epac-stimulated Cl current to previ-
ously identified intestinal epithelial channels, we charac-
terized its ion selectivity, I-V characteristics, and blocker 
sensitivity. The Epac-mediated current was inwardly recti-
fying, was sensitive to BAPTA-AM and thus Ca2+ sensitive, 
had a halide selectivity of Cl>Br>I, and was not sensi-
tive to Cd2+, Zn2+, CFTRinh-172, or niflumic acid, but was 
sensitive to DIDS, NPPB, and GlyH-101. CFTR Cl cur-
rents are distinguished by a linear I-V relation, lack of a 
time-dependent current decay, activation by PKA, and in-
hibition by diphenylamine-2-carboxylate, glibenclamide, 
and CFTRinh-172, but not by DIDS (Gray et al., 1993; 
McCarty et al., 1993). The halide selectivity sequence most 
Figure 11. Model showing the FSK-stimulated PKA- and Epac-
dependent (PKA-independent) signaling pathways of epithelial Cl 
secretion in T84 cells. The dotted arrows and the solid arrows are 
used to indicate the PKA or Epac1 pathways, respectively, which 
run in parallel downstream of cAMP. AC, adenylate cyclase; PLC, 
phospholipase C; DAG, diacylglycerol; PIP2, phosphatidylinositol 
4,5-bisphosphate; IP3, inositol 1,4,5 triphosphate; ER, endoplas-
mic reticulum; ?, unknown Cl channels regulated by Epac.
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Our data show that Epac1 signaling stimulates an in-
wardly rectifying current that is not blocked by Cd2+, 
Zn2+, niflumic acid, CFTRinh-172, or glibenclamide 
when the current is directly stimulated by 8-pCPT-2’-O-
Me-cAMP. Cl currents are completely inhibited by 
DIDS or NPPB (also blockers of CaCC) when FSK in the 
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Epac-mediated intestinal Cl secretion in T84 cells and 
net ion transport in mouse ileum. The Icl activated by 
Epac that we have identified and given an initial bio-
physical characterization might be useful in cystic fibro-
sis disease by providing an alternative source of chloride 
movement when the CFTR channel is defective.
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